Coagulation Disorders & Thrombosis Sub-Study
This subgroup will focus on physiologic changes in COVID patients related to hemostasis and how these factors are associated with bleeding and thrombotic complications in COVID 19 patients. Use of anticoagulants and observed outcomes will also be explored. Laboratory measures, administered medications, complications, bleeding and thrombotic events and interventions will also be tracked and evaluated. Associations with non-COVID patients if available or those with other viral diseases may also be investigated.
How to get involved
1. If you are interested in participating in this sub-study please contact the Principal Investigator:
Heidi Dalton: heidi.dalton26@gmail.com
2. You will need to submit the COVID Critical Protocol to your IRB for approval. The protocol is available here.
3. Email your IRB approval/amendment document to ECMOCARD@health.qld.gov.au and we will arrange REDCap access to the sub-study fields.
Last Updated April 28, 2021